Morgan Stanley has upgraded Lemonade Inc. from Equal Weight to Overweight, simultaneously increasing its price target from $80 to $85. This positive revision suggests a more optimistic outlook for the insurtech company's stock performance.

Morgan Stanley Upgrades Lemonade to Overweight, Raises Price Target
LemonadeStockUpgradeAnalystRatingInsurtech



